Showing posts with label Open Science. Show all posts
Showing posts with label Open Science. Show all posts

Sunday, January 30, 2022

Massive open index of scholarly papers launches; Nature, January 24, 2022

 Dalmeet Singh Chawla , Nature; Massive open index of scholarly papers launches

"An ambitious free index of more than 200 million scientific documents that catalogues publication sources, author information and research topics, has been launched.

The index, called OpenAlex after the ancient Library of Alexandria in Egypt, also aims to chart connections between these data points to create a comprehensive, interlinked database of the global research system, say its founders. The database, which launched on 3 January, is a replacement for Microsoft Academic Graph (MAG), a free alternative to subscription-based platforms such as Scopus, Dimensions and Web of Science that was discontinued at the end of 2021."

Saturday, March 31, 2018

Tuesday, February 14, 2017

Open Science: Beyond Open Access webinar; Library Journal, February 21, 2017

Library Journal; Open Science: Beyond Open Access webinar


"Open Science: Beyond Open Access

LJwebcast_02212017_Dove_Header_550px
Presented by: Dove Press & Library Journal
Event Date & Time: Tuesday, February 21st, 2017, 3:00 PM – 4:00 PM ET / 12:00 PM – 1:00 PM PT
Register
Collaboration can be a major driver for success. When data is shared among researchers, analysts and stakeholders, the opportunities for innovation and development increase exponentially, particularly in the medical and science fields. To be most effective, the Open Science framework demands more than simply sharing data–it requires dedication, transparency and responsible publishing.
Join this webcast to learn from our panel of experts as they discuss the challenges and benefits of Open Science in the context of global health and medical concerns. They will explain how the disruptive concept of Open Data can reshape and improve the nature of research and results.

Panelists

  • Dr. Eric Little, VP of Data Science, OSTHUS
  • Dr. Robin Bloor, Chief Analyst, The Bloor Group
  • Andrew Johnson, Research Data Librarian/Assistant Professor, University of Colorado Boulder

Moderator

  • Rebecca Jozwiak, Editorial & Research Director, The Bloor Group"

Thursday, December 1, 2016

Australian students recreate Martin Shkreli price-hike drug in school lab; Guardian, 11/30/16

Melissa Davey, Guardian; Australian students recreate Martin Shkreli price-hike drug in school lab:
"He said the open nature of the project demystified science and revealed the number of roadblocks the students had faced in coming up with the final product, which involved three complicated chemical steps.
“With science results you can be presented with a polished finished product that hides the false steps along the way,” he said. “The students’ real-time diary highlights their whole process, and is a very transparent way of doing things.”...
He said unfortunately the students would not be able to sell their drug to the US market. While the drug can be bought in Australia for about A$13 for a packet of 50, there are a number of complicated legal roadblocks in the way of producing and selling it in the US.
“Turing has the exclusive rights to sell it, even though the drug is no longer under patent,” Todd said. “The ridiculousness of this legal loophole means if we wanted to launch it as drug in the US we’d have to go through a whole new clinical trial because we would have to compare the Sydney Grammar stuff with the officially sanctioned stuff, and Turing would have to give us the drug to allow those comparisons to be made."

Monday, July 4, 2016

NASA’s Juno orbiter set to arrive at Jupiter on Monday; Washington Post, 7/4/16

Rachel Feltman, Washington Post; NASA’s Juno orbiter set to arrive at Jupiter on Monday:
[Kip Currier: What a fitting testament NASA's Juno orbiter mission to Jupiter is to reason, shared human endeavor, and Open Science on this day, the USA's 240th birthday.]
"Take a break from your all-American cookout tonight to look up at the sky and think of Juno. On Monday, the football-field-size spacecraft will zip into Jupiter's orbit, allowing us to study the secrets of our solar system's biggest, oldest planet for the first time.
Other spacecraft have visited Jupiter before. But Juno will orbit closer than any of them – within 2,700 miles of the planet's cloud cover – and allow scientists to probe for data from beneath the giant planet's roiling, gassy surface.
"We're barreling down on Jupiter really quick," principal investigator Scott Bolton of the Southwest Research Institute said at a news briefing held at NASA's Jet Propulsion Lab in California on Monday. "It's been an amazing journey."
Around 1:30 p.m. Eastern, he said, Juno passed Europa – the Jovian moon that has subsurface oceans where future missions may look for signs of life. Around half an hour later, it passed Io, the innermost moon.
"In one Jupiter rotation, we'll be there," said Jim Green, director of planetary science for NASA. "What a wonderful day to celebrate. It's a milestone for our country, but also for planetary science.""

Tuesday, March 15, 2016

Handful of Biologists Went Rogue and Published Directly to Internet; New York Times, 3/15/16

Amy Harmon, New York Times; Handful of Biologists Went Rogue and Published Directly to Internet:
"On Feb. 29, Carol Greider of Johns Hopkins University became the third Nobel Prize laureate biologist in a month to do something long considered taboo among biomedical researchers: She posted a report of her recent discoveries to a publicly accessible website, bioRxiv, before submitting it to a scholarly journal to review for “official’’ publication.
It was a small act of information age defiance, and perhaps also a bit of a throwback, somewhat analogous to Stephen King’s 2000 self-publishing an e-book or Radiohead’s 2007 release of a download-only record without a label. To commemorate it, she tweeted the website’s confirmation under the hashtag #ASAPbio, a newly coined rallying cry of a cadre of biologists who say they want to speed science by making a key change in the way it is published...
The delays prevent scientists from showing off their most recent work to prospective employers or benefactors. They have also, some researchers say, begun to look faintly absurd against the general expectations for speed and openness in the not-so-new digital age. With the rapid spread of the Zika virus, for instance, several journals signed a statement promising that scientists would not be penalized for immediately releasing their findings, given the potential benefit for public health, in turn prompting some scientists to ask, why draw the line at Zika?"